Gilead Sciences Inc (GILD)
92.11
-0.52
(-0.56%)
USD |
NASDAQ |
Nov 14, 16:00
92.12
+0.01
(+0.01%)
After-Hours: 20:00
Gilead Sciences Free Cash Flow (Quarterly): 4.544B for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.544B |
| June 30, 2024 | 1.195B |
| March 31, 2024 | 2.114B |
| December 31, 2023 | 1.954B |
| September 30, 2023 | 1.633B |
| June 30, 2023 | 2.199B |
| March 31, 2023 | 1.635B |
| December 31, 2022 | 2.386B |
| September 30, 2022 | 2.706B |
| June 30, 2022 | 1.659B |
| March 31, 2022 | 1.593B |
| December 31, 2021 | 3.049B |
| September 30, 2021 | 3.114B |
| June 30, 2021 | 2.197B |
| March 31, 2021 | 2.445B |
| December 31, 2020 | 1.735B |
| September 30, 2020 | 2.095B |
| June 30, 2020 | 2.423B |
| March 31, 2020 | 1.265B |
| December 31, 2019 | 2.377B |
| September 30, 2019 | 2.445B |
| June 30, 2019 | 2.157B |
| March 31, 2019 | 1.34B |
| December 31, 2018 | 2.097B |
| September 30, 2018 | 2.045B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.276B |
| March 31, 2018 | 2.058B |
| December 31, 2017 | 2.533B |
| September 30, 2017 | 2.565B |
| June 30, 2017 | 3.403B |
| March 31, 2017 | 2.807B |
| December 31, 2016 | 3.37B |
| September 30, 2016 | 4.195B |
| June 30, 2016 | 4.781B |
| March 31, 2016 | 3.953B |
| December 31, 2015 | 5.629B |
| September 30, 2015 | 3.81B |
| June 30, 2015 | 5.487B |
| March 31, 2015 | 5.577B |
| December 31, 2014 | 2.854B |
| September 30, 2014 | 3.909B |
| June 30, 2014 | 4.094B |
| March 31, 2014 | 1.404B |
| December 31, 2013 | 658.11M |
| September 30, 2013 | 715.92M |
| June 30, 2013 | 907.73M |
| March 31, 2013 | 633.25M |
| December 31, 2012 | 436.19M |
| September 30, 2012 | 678.78M |
| June 30, 2012 | 1.253B |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
1.195B
Minimum
Jun 2024
4.544B
Maximum
Sep 2024
2.216B
Average
2.156B
Median
Free Cash Flow (Quarterly) Benchmarks
| Eli Lilly and Co | -458.90M |
| Merck & Co Inc | 8.508B |
| Vertex Pharmaceuticals Inc | 1.302B |
| Amgen Inc | 3.314B |
| Pfizer Inc | 6.063B |